[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Extracorporeal Membrane Oxygenation System Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2020 | 94 pages | ID: E06EC3B3FAA8EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Extracorporeal Membrane Oxygenation System market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Extracorporeal Membrane Oxygenation System market segmented into
  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)
Based on the end-use, the global Extracorporeal Membrane Oxygenation System market classified into
  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Based on geography, the global Extracorporeal Membrane Oxygenation System market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Getinge Group
  • Medtronic plc
  • LivaNova PLC
  • XENIOS AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • NIPRO Corporation
  • OriGen Biomedical, Inc.
  • ALung Technologies, Inc.
  • EUROSETS S.r.l.
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM INDUSTRY

2.1 Summary about Extracorporeal Membrane Oxygenation System Industry
2.2 Extracorporeal Membrane Oxygenation System Market Trends
  2.2.1 Extracorporeal Membrane Oxygenation System Production & Consumption Trends
  2.2.2 Extracorporeal Membrane Oxygenation System Demand Structure Trends
2.3 Extracorporeal Membrane Oxygenation System Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Veno-Arterial (VA)
  4.2.2 Veno-Venous (VV)
  4.2.3 Arterio-Venous (AV)
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Respiratory
  4.3.2 Cardiac
  4.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Veno-Arterial (VA)
  5.2.2 Veno-Venous (VV)
  5.2.3 Arterio-Venous (AV)
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Respiratory
  5.3.2 Cardiac
  5.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Veno-Arterial (VA)
  6.2.2 Veno-Venous (VV)
  6.2.3 Arterio-Venous (AV)
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Respiratory
  6.3.2 Cardiac
  6.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Veno-Arterial (VA)
  7.2.2 Veno-Venous (VV)
  7.2.3 Arterio-Venous (AV)
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Respiratory
  7.3.2 Cardiac
  7.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Veno-Arterial (VA)
  8.2.2 Veno-Venous (VV)
  8.2.3 Arterio-Venous (AV)
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Respiratory
  8.3.2 Cardiac
  8.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Veno-Arterial (VA)
  9.2.2 Veno-Venous (VV)
  9.2.3 Arterio-Venous (AV)
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Respiratory
  9.3.2 Cardiac
  9.3.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Getinge Group
  10.1.2 Medtronic plc
  10.1.3 LivaNova PLC
  10.1.4 XENIOS AG
  10.1.5 Terumo Corporation
  10.1.6 MicroPort Scientific Corporation
  10.1.7 NIPRO Corporation
  10.1.8 OriGen Biomedical, Inc.
  10.1.9 ALung Technologies, Inc.
  10.1.10 EUROSETS S.r.l.
10.2 Extracorporeal Membrane Oxygenation System Sales Date of Major Players (2017-2020e)
  10.2.1 Getinge Group
  10.2.2 Medtronic plc
  10.2.3 LivaNova PLC
  10.2.4 XENIOS AG
  10.2.5 Terumo Corporation
  10.2.6 MicroPort Scientific Corporation
  10.2.7 NIPRO Corporation
  10.2.8 OriGen Biomedical, Inc.
  10.2.9 ALung Technologies, Inc.
  10.2.10 EUROSETS S.r.l.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Extracorporeal Membrane Oxygenation System Product Type Overview
2.Table Extracorporeal Membrane Oxygenation System Product Type Market Share List
3.Table Extracorporeal Membrane Oxygenation System Product Type of Major Players
4.Table Brief Introduction of Getinge Group
5.Table Brief Introduction of Medtronic plc
6.Table Brief Introduction of LivaNova PLC
7.Table Brief Introduction of XENIOS AG
8.Table Brief Introduction of Terumo Corporation
9.Table Brief Introduction of MicroPort Scientific Corporation
10.Table Brief Introduction of NIPRO Corporation
11.Table Brief Introduction of OriGen Biomedical, Inc.
12.Table Brief Introduction of ALung Technologies, Inc.
13.Table Brief Introduction of EUROSETS S.r.l.
14.Table Products & Services of Getinge Group
15.Table Products & Services of Medtronic plc
16.Table Products & Services of LivaNova PLC
17.Table Products & Services of XENIOS AG
18.Table Products & Services of Terumo Corporation
19.Table Products & Services of MicroPort Scientific Corporation
20.Table Products & Services of NIPRO Corporation
21.Table Products & Services of OriGen Biomedical, Inc.
22.Table Products & Services of ALung Technologies, Inc.
23.Table Products & Services of EUROSETS S.r.l.
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Extracorporeal Membrane Oxygenation System Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Extracorporeal Membrane Oxygenation System Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Extracorporeal Membrane Oxygenation System Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Extracorporeal Membrane Oxygenation System Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Extracorporeal Membrane Oxygenation System Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Extracorporeal Membrane Oxygenation System Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Extracorporeal Membrane Oxygenation System Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Extracorporeal Membrane Oxygenation System Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Extracorporeal Membrane Oxygenation System Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Extracorporeal Membrane Oxygenation System Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Extracorporeal Membrane Oxygenation System Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Veno-Arterial (VA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Veno-Venous (VV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Arterio-Venous (AV) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Respiratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Cardiac Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Extracorporeal Cardiopulmonary Resuscitation (ECPR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Extracorporeal Membrane Oxy


More Publications